The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreAs Seen in Ynetnews.com
A first-of-its-kind treatment in Israel was recently performed at Rambam Health Care Campus, where specialists helped a man in his 40s detox from an extreme dependence on opioid painkillers, which had reached about 130 pills a day, in a procedure that lasted just 20 minutes.
The treatment was carried out using unique Israeli technology developed by Insightec, as part of an international study underway at a small number of medical centers in the United States, and now also in Israel.
“This is a new therapeutic platform that allows us to offer a range of noninvasive treatments for many problems affecting people around the world,” said Dr. Lior Lev Tov, head of the Functional Neurosurgery Unit in Rambam’s neurosurgery department and the study’s lead investigator. “This is a major scientific breakthrough that could have far-reaching implications and reshape the way we approach treatment.”
Multiple Insightec senior leaders — including Co-founder Jacob (Kobi) Vortman, Chief Scientific Officer Yoav Levy, and Chief Operating Officer Eyal Zadicario — are Technion – Israel Institute of Technology alumni.